{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:21:57Z","timestamp":1789608117975,"version":"build-2803163510"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 NS098819"],"award-info":[{"award-number":["RO1 NS098819"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS040389"],"award-info":[{"award-number":["R01 NS040389"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01 NS058901"],"award-info":[{"award-number":["P01 NS058901"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013013","name":"Target ALS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013013","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005725","name":"CHDI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002243","name":"National Ataxia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000971","name":"ALS Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Packard Foundation, The Marigold Foundation and the Muscular Dystrophy Association"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Genetics &amp; Development"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.gde.2017.03.006","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T23:47:36Z","timestamp":1490917656000},"page":"125-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["New developments in RAN translation: insights from multiple diseases"],"prefix":"10.1016","volume":"44","author":[{"given":"John Douglas","family":"Cleary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura PW","family":"Ranum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gde.2017.03.006_bib0005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1073\/pnas.1013343108","article-title":"Non-ATG-initiated translation directed by microsatellite expansions","volume":"108","author":"Zu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2017.03.006_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.gde.2014.03.002","article-title":"Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders","volume":"26","author":"Cleary","year":"2014","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.gde.2017.03.006_bib0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuron.2013.03.026","article-title":"CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome","volume":"78","author":"Todd","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_bib0020","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1126\/science.1232927","article-title":"The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD\/ALS","volume":"339","author":"Mori","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.gde.2017.03.006_bib0025","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00401-013-1189-3","article-title":"Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins","author":"Mori","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.gde.2017.03.006_bib0030","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1073\/pnas.1315438110","article-title":"RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia","author":"Zu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2017.03.006_bib0035","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neuron.2013.02.004","article-title":"Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD\/ALS","volume":"77","author":"Ash","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_bib0040","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00401-013-1192-8","article-title":"Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD\/ALS","author":"Gendron","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.gde.2017.03.006_bib0045","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.neuro.29.051605.113042","article-title":"Trinucleotide repeat disorders","volume":"30","author":"Orr","year":"2007","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.gde.2017.03.006_bib0050","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.gde.2017.03.006_sbref0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.neuron.2015.10.038","article-title":"RAN translation in Huntington disease","volume":"88","author":"Ba\u00f1ez-Coronel","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_bib0060","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/NEN.0b013e318198d320","article-title":"Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains","volume":"68","author":"Herndon","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.gde.2017.03.006_bib0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11682-011-9121-8","article-title":"Diffusion tensor imaging in Huntington\u2019s disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits","volume":"5","author":"Bohanna","year":"2011","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.gde.2017.03.006_bib0070","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1212\/01.WNL.0000138434.68093.67","article-title":"In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease","volume":"63","author":"Fennema-Notestine","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.gde.2017.03.006_bib0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresbull.2010.04.003","article-title":"Striatal and white matter predictors of estimated diagnosis for Huntington disease","volume":"82","author":"Paulsen","year":"2010","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.gde.2017.03.006_bib0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pscychresns.2005.05.011","article-title":"Regional white matter change in pre-symptomatic Huntington\u2019s disease: a diffusion tensor imaging study","volume":"140","author":"Reading","year":"2005","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.gde.2017.03.006_bib0085","doi-asserted-by":"crossref","first-page":"11270","DOI":"10.1093\/nar\/gks907","article-title":"Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway","volume":"40","author":"Hu","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gde.2017.03.006_bib0090","doi-asserted-by":"crossref","first-page":"e107434","DOI":"10.1371\/journal.pone.0107434","article-title":"Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patients","volume":"9","author":"Skotte","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.gde.2017.03.006_bib0095","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_bib0100","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12035-012-8316-3","article-title":"Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II","volume":"46","author":"Switonski","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.gde.2017.03.006_bib0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2016.04.041","article-title":"Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro","volume":"108","author":"Walter","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.gde.2017.03.006_sbref0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.neuron.2016.03.016","article-title":"PIAS1 regulates mutant huntingtin accumulation and Huntington\u2019s disease-associated phenotypes in vivo","volume":"90","author":"Ochaba","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_bib0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fnmol.2014.00063","article-title":"Ubiquitin pathways in neurodegenerative disease","volume":"7","author":"Atkin","year":"2014","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.gde.2017.03.006_bib0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fnmol.2016.00027","article-title":"Subcellular clearance and accumulation of Huntington disease protein: a mini-review","volume":"9","author":"Zhao","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.gde.2017.03.006_bib0125","doi-asserted-by":"crossref","first-page":"e0128769","DOI":"10.1371\/journal.pone.0128769","article-title":"Repeat associated non-AUG translation (RAN translation) dependent on sequence downstream of the ATXN2 CAG repeat","volume":"10","author":"Scoles","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.gde.2017.03.006_bib0130","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fncel.2016.00226","article-title":"Regulation of mRNA translation by MID1: a common mechanism of expanded CAG repeat RNAs","volume":"10","author":"Griesche","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.gde.2017.03.006_bib0135","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ana.24800","article-title":"RAN translation from antisense CCG repeats in fragile X tremor\/ataxia syndrome","author":"Krans","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2017.03.006_sbref0140","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.molcel.2016.02.034","article-title":"CGG repeat-associated non-AUG translation utilizes a cap-dependent scanning mechanism of initiation to produce toxic proteins","volume":"62","author":"Kearse","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.gde.2017.03.006_sbref0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuron.2016.12.016","article-title":"Translation of expanded CGG repeats into FMRpolyG is pathogenic and may contribute to fragile X tremor ataxia syndrome","author":"Sellier","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_bib0150","doi-asserted-by":"crossref","first-page":"7507","DOI":"10.1073\/pnas.0810916106","article-title":"Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans","volume":"106","author":"Calvo","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2017.03.006_bib0155","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2011.10.002","article-title":"Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes","volume":"147","author":"Ingolia","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.gde.2017.03.006_bib0160","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1101\/gad.1427006","article-title":"Downstream control of upstream open reading frames","volume":"20","author":"Sachs","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.gde.2017.03.006_bib0165","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1128\/MCB.20.23.8635-8642.2000","article-title":"Upstream open reading frames as regulators of mRNA translation","volume":"20","author":"Morris","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.gde.2017.03.006_bib0170","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1093\/hmg\/ddi394","article-title":"Induction of inclusion formation and disruption of lamin A\/C structure by premutation CGG-repeat RNA in human cultured neural cells","volume":"14","author":"Arocena","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2017.03.006_bib0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","article-title":"Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS","volume":"72","author":"DeJesus-Hernandez","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_bib0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuron.2013.10.015","article-title":"RNA toxicity from the ALS\/FTD C9ORF72 expansion is mitigated by antisense intervention","volume":"80","author":"Donnelly","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_bib0185","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00401-013-1149-y","article-title":"Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons","author":"Almeida","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.gde.2017.03.006_bib0190","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00401-013-1199-1","article-title":"Reduced C9orf72 gene expression in c9FTD\/ALS is caused by histone trimethylation, an epigenetic event detectable in blood","author":"Belzil","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.gde.2017.03.006_bib0195","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.neurobiolaging.2014.01.016","article-title":"Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion","volume":"35","author":"Waite","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.gde.2017.03.006_bib0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature13124","article-title":"C9orf72 nucleotide repeat structures initiate molecular cascades of disease","volume":"507","author":"Haeusler","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.gde.2017.03.006_bib0205","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/brain\/awu120","article-title":"Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions","volume":"137","author":"Cooper-Knock","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.gde.2017.03.006_bib0210","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00401-013-1088-7","article-title":"hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive\/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations","volume":"125","author":"Mori","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.gde.2017.03.006_bib0215","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19032","article-title":"Suppression of C9orf72 RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106","volume":"6","author":"Celona","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.gde.2017.03.006_bib0220","doi-asserted-by":"crossref","first-page":"7778","DOI":"10.1073\/pnas.1219643110","article-title":"Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration","volume":"110","author":"Xu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2017.03.006_bib0225","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.celrep.2013.10.049","article-title":"Hexanucleotide repeats in ALS\/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic","volume":"5","author":"Lee","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.gde.2017.03.006_sbref0230","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.aaa9344","article-title":"Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits","volume":"348","author":"Chew","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.gde.2017.03.006_bib0235","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00401-015-1476-2","article-title":"Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers","volume":"130","author":"Mackenzie","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.gde.2017.03.006_bib0240","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00401-013-1181-y","article-title":"Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations","author":"Mackenzie","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.gde.2017.03.006_bib0245","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/2051-5960-1-68","article-title":"Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72","volume":"1","author":"Mann","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.gde.2017.03.006_bib0250","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn.2016.38","article-title":"The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease","volume":"17","author":"Haeusler","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.gde.2017.03.006_bib0255","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature20413","article-title":"Decoding ALS: from genes to mechanism","volume":"539","author":"Taylor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.gde.2017.03.006_bib0260","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2016.09.007","article-title":"Pathogenic determinants and mechanisms of ALS\/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene","volume":"636","author":"Wen","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.gde.2017.03.006_bib0265","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-016-1587-4","article-title":"ALS and FTD: an epigenetic perspective","volume":"132","author":"Belzil","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"Suppl. 1","key":"10.1016\/j.gde.2017.03.006_bib0270","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/jnc.13623","article-title":"Insights into the pathogenic mechanisms of chromosome 9 open reading frame 72 (C9orf72) repeat expansions","volume":"138","author":"Todd","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.gde.2017.03.006_bib0275","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/hmg\/ddw052","article-title":"Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation","volume":"25","author":"Kanekura","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2017.03.006_bib0280","doi-asserted-by":"crossref","first-page":"E1111","DOI":"10.1073\/pnas.1620293114","article-title":"Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export","author":"Shi","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2017.03.006_bib0285","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cell.2016.10.002","article-title":"C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles","volume":"167","author":"Lee","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.gde.2017.03.006_bib0290","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2016.10.003","article-title":"Toxic PR poly-dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers","volume":"167","author":"Lin","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.gde.2017.03.006_sbref0295","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature14973","article-title":"The C9orf72 repeat expansion disrupts nucleocytoplasmic transport","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.gde.2017.03.006_bib0300","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/01677063.2015.1085980","article-title":"Epidemiology and molecular mechanism of frontotemporal lobar degeneration\/amyotrophic lateral sclerosis with repeat expansion mutation in C9orf72","volume":"29","author":"Ishiura","year":"2015","journal-title":"J Neurogenet"},{"key":"10.1016\/j.gde.2017.03.006_bib0305","doi-asserted-by":"crossref","first-page":"20877","DOI":"10.1038\/srep20877","article-title":"Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS\/FTD","volume":"6","author":"Boeynaems","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.gde.2017.03.006_sbref0310","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/nn.4085","article-title":"Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD\/ALS","volume":"18","author":"Jovicic","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.gde.2017.03.006_sbref0315","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature14974","article-title":"GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport","volume":"525","author":"Freibaum","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.gde.2017.03.006_bib0320","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-016-1586-5","article-title":"Inside out: the role of nucleocytoplasmic transport in ALS and FTLD","volume":"132","author":"Boeynaems","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.gde.2017.03.006_bib0325","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.cell.2016.01.034","article-title":"The nuclear pore complex as a flexible and dynamic gate","volume":"164","author":"Knockenhauer","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.gde.2017.03.006_bib0330","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1126\/science.aad2033","article-title":"Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA","volume":"351","author":"Woerner","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.gde.2017.03.006_bib0335","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/embor.2011.86","article-title":"RNA steady-state defects in myotonic dystrophy are linked to nuclear exclusion of SHARP","volume":"12","author":"Dansithong","year":"2011","journal-title":"EMBO Rep"},{"key":"10.1016\/j.gde.2017.03.006_bib0340","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/hmg\/ddg156","article-title":"Huntingtin contains a highly conserved nuclear export signal","volume":"12","author":"Xia","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2017.03.006_bib0345","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1083\/jcb.153.2.283","article-title":"Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression","volume":"153","author":"Suhr","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.gde.2017.03.006_bib0350","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ng1503","article-title":"Polyglutamine expansion of huntingtin impairs its nuclear export","volume":"37","author":"Cornett","year":"2005","journal-title":"Nat Genet"},{"issue":"Pt. 3","key":"10.1016\/j.gde.2017.03.006_bib0355","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1042\/bj3510587","article-title":"Aberrant phosphorylation of dentatorubral-pallidoluysian atrophy (DRPLA) protein complex in brain tissue","volume":"351","author":"Yazawa","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.gde.2017.03.006_bib0360","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0006-8993(01)02986-9","article-title":"Neuronal nuclear alterations in dentatorubral-pallidoluysian atrophy: ultrastructural and morphometric studies of the cerebellar granule cells","volume":"919","author":"Takahashi","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.gde.2017.03.006_bib0365","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1074\/jbc.M506751200","article-title":"Ataxin-7 can export from the nucleus via a conserved exportin-dependent signal","volume":"281","author":"Taylor","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.gde.2017.03.006_bib0370","doi-asserted-by":"crossref","first-page":"9310","DOI":"10.1073\/pnas.152101299","article-title":"Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis","volume":"99","author":"Chai","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2017.03.006_sbref0375","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.neuron.2015.10.027","article-title":"C9orf72 BAC transgenic mice display typical pathologic features of ALS\/FTD","volume":"88","author":"O'Rourke","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_sbref0380","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.neuron.2015.11.018","article-title":"Human C9ORF72 hexanucleotide expansion reproduces RNA foci and dipeptide repeat proteins but not neurodegeneration in BAC transgenic mice","volume":"88","author":"Peters","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_sbref0385","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.neuron.2016.04.006","article-title":"Gain of toxicity from ALS\/FTD-linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-containing RNAs","volume":"90","author":"Jiang","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_sbref0390","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.neuron.2016.04.005","article-title":"C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS\/FTD","volume":"90","author":"Liu","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_bib0395","doi-asserted-by":"crossref","first-page":"E4530","DOI":"10.1073\/pnas.1318835110","article-title":"Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration","volume":"110","author":"Lagier-Tourenne","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2017.03.006_bib0400","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11362","article-title":"Targeting nuclear RNA for in vivo correction of myotonic dystrophy","volume":"488","author":"Wheeler","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.gde.2017.03.006_bib0405","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/mt.2013.279","article-title":"Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy","volume":"22","author":"Keiser","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.gde.2017.03.006_bib0410","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.gt.3302664","article-title":"RNAi: a potential therapy for the dominantly inherited nucleotide repeat diseases","volume":"13","author":"Denovan-Wright","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.gde.2017.03.006_bib0415","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/mt.2013.152","article-title":"Silencing mutant ATXN3 expression resolves molecular phenotypes in SCA3 transgenic mice","volume":"21","author":"Rodr\u00edguez-Lebr\u00f3n","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.gde.2017.03.006_bib0420","doi-asserted-by":"crossref","first-page":"E4530","DOI":"10.1073\/pnas.1318835110","article-title":"Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration","author":"Lagier-Tourenne","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2017.03.006_sbref0425","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.aaf7791","article-title":"Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts","volume":"353","author":"Kramer","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.gde.2017.03.006_bib0430","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.neuron.2011.05.027","article-title":"CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA","volume":"70","author":"Sopher","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_bib0435","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nn.4272","article-title":"C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins","volume":"19","author":"Zhang","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.gde.2017.03.006_bib0440","doi-asserted-by":"crossref","first-page":"18551","DOI":"10.1073\/pnas.0903234106","article-title":"Pentamidine reverses the splicing defects associated with myotonic dystrophy","volume":"106","author":"Warf","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2017.03.006_bib0445","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1093\/nar\/gku275","article-title":"Lomofungin and dilomofungin: inhibitors of MBNL1-CUG RNA binding with distinct cellular effects","volume":"42","author":"Hoskins","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gde.2017.03.006_bib0450","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/cb200408a","article-title":"Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive","volume":"7","author":"Childs-Disney","year":"2012","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.gde.2017.03.006_bib0455","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1021\/cb3001606","article-title":"Rational design of bioactive, modularly assembled aminoglycosides targeting the RNA that causes myotonic dystrophy type 1","volume":"7","author":"Childs-Disney","year":"2012","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.gde.2017.03.006_bib0460","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1093\/nar\/gks298","article-title":"From dynamic combinatorial \u2018hit\u2019 to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy","volume":"40","author":"Ofori","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.gde.2017.03.006_bib0465","doi-asserted-by":"crossref","first-page":"11866","DOI":"10.1073\/pnas.1018213108","article-title":"In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models","volume":"108","author":"Garc\u00eda-L\u00f3pez","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2017.03.006_bib0470","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.cell.2011.12.032","article-title":"Spt4 is selectively required for transcription of extended trinucleotide repeats","volume":"148","author":"Liu","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.gde.2017.03.006_bib0475","doi-asserted-by":"crossref","first-page":"e1005043","DOI":"10.1371\/journal.pgen.1005043","article-title":"Effects on murine behavior and lifespan of selectively decreasing expression of mutant huntingtin allele by supt4\u2009h knockdown","volume":"11","author":"Cheng","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.gde.2017.03.006_bib0480","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1093\/hmg\/ddq132","article-title":"Partners in crime: bidirectional transcription in unstable microsatellite disease","volume":"19","author":"Batra","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2017.03.006_bib0485","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ng1827","article-title":"Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8","volume":"38","author":"Moseley","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.gde.2017.03.006_bib0490","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1093\/hmg\/ddm293","article-title":"An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals","volume":"16","author":"Ladd","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gde.2017.03.006_bib0495","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.molcel.2005.09.002","article-title":"Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF","volume":"20","author":"Cho","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.gde.2017.03.006_bib0500","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","article-title":"A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD","volume":"72","author":"Renton","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.gde.2017.03.006_bib0505","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ana.24453","article-title":"C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits","volume":"78","author":"Koppers","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gde.2017.03.006_bib0510","doi-asserted-by":"crossref","first-page":"23204","DOI":"10.1038\/srep23204","article-title":"C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice","volume":"6","author":"Atanasio","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.gde.2017.03.006_bib0515","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-1-4939-1221-6_10","article-title":"RNA-binding protein misregulation in microsatellite expansion disorders","volume":"825","author":"Goodwin","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.gde.2017.03.006_bib0520","doi-asserted-by":"crossref","first-page":"E4968","DOI":"10.1073\/pnas.1315438110","article-title":"RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia","volume":"110","author":"Zu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gde.2017.03.006_sbref0525","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.celrep.2016.09.032","article-title":"Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS\/FTD","volume":"17","author":"Westergard","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.gde.2017.03.006_bib0530","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.neuron.2014.07.041","article-title":"Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD\/ALS","volume":"83","author":"Su","year":"2014","journal-title":"Neuron"}],"container-title":["Current Opinion in Genetics &amp; Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X17300254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959437X17300254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T13:32:10Z","timestamp":1582551130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959437X17300254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":106,"alternative-id":["S0959437X17300254"],"URL":"https:\/\/doi.org\/10.1016\/j.gde.2017.03.006","relation":{},"ISSN":["0959-437X"],"issn-type":[{"value":"0959-437X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New developments in RAN translation: insights from multiple diseases","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Genetics & Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gde.2017.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}